Group 1 - The company held a half-year performance and cash dividend briefing on September 5, 2025, to provide investors with insights into its 2025 half-year operating results and financial status [1][2] - Key personnel attending the briefing included the Chairman, General Manager, Independent Director, Board Secretary, and Chief Financial Officer, who engaged with investors on common concerns [2] Group 2 - The main factors contributing to the company's year-on-year performance growth in the first half of 2025 include increased sales prices of products such as barium carbonate, strontium carbonate, barium sulfate, and sulfur, as well as higher sales volumes of high-value-added products [3] - The company established a wholly-owned subsidiary in Tianzhu County, Guizhou Province, to leverage local resource advantages, reduce raw material procurement costs, and enhance profitability [3][4] - The construction and installation of the Chongqing Ruide Sida strontium salt project are nearing completion, with trial production expected to begin in late September 2025 [4] Group 3 - The average sales price of strontium carbonate reached approximately 8,500 yuan per ton (including tax) in August 2025, indicating a decline from the peak in April 2025 [5]

股票简称：红星发展 股票代码：600367 编号：临 2025-041 贵州红星发展股份有限公司 2025 年半年度业绩暨现金分红说明会召开情况公告 公司 2025 年上半年业绩同比增加的主要因素有：一是公司碳酸钡、碳酸锶、硫 酸钡及硫磺等产品销售价格同比增加；二是公司高附加值产品高纯钡、氢氧化钡、 高纯锶等产品销售量增加，增加了公司利润；三是公司合理管控成本费用，推进精 1 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、本次说明会召开情况 贵州红星发展股份有限公司（下称公司）已于 2025 年 8 月 23 日发布公司 2025 年半年度报告，为便于广大投资者更全面深入地了解公司 2025 年半年度经营成果、 财 务 状 况 ， 公 司 于 2025 年 9 月 5 日 下 午 14:00-15:00 通 过 上 证 路 演 中 心 （http://roadshow.sseinfo.com/）召开了 2025 年半年度业绩暨现金分红说明会， 就投资者关心的问题进行交流。 二、公司参加本次说明会的人员 2025 年 ...

Market Overview - On September 5, the chemical raw materials sector rose by 2.24%, with Hongxing Development leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Hongxing Development (600367) closed at 18.01, with a gain of 10.02% and a trading volume of 189,300 shares, totaling a transaction value of 334 million [1] - Other notable performers included: - Kaisheng New Materials (301069) at 22.69, up 6.43%, with a transaction value of 454 million [1] - Sanxiang New Materials (603663) at 29.80, up 6.39%, with a transaction value of 1.033 billion [1] - Ti'an Co. (603067) at 17.32, up 6.19%, with a transaction value of 416 million [1] Capital Flow - The chemical raw materials sector saw a net inflow of 363 million from institutional investors, while retail investors experienced a net outflow of 335 million [2][3] - The main capital inflow was concentrated in: - Hongxing Development with a net inflow of 1.29 billion, accounting for 38.52% of its trading volume [3] - Sanxiang New Materials with a net inflow of 105 million, accounting for 10.14% [3] - Kaisheng New Materials with a net inflow of 44.64 million, accounting for 9.84% [3]

Core Insights - The lithium battery sector is experiencing a surge in interest, with companies like Tianji Co., Fengyuan Co., Jinyinhai Co., Hongxing Development, and Guanghua Technology leading the charge [1] Company Summaries - ***ST Zhengping (603843.SS)**: Achieved a "3 consecutive limit up" with a latest price of 3.07 yuan, up 5.14%. The company is focusing on resource expansion through lithium mining projects in Pakistan and Morocco, which is driving its stock price [1] - **Tianji Co. (002759.SZ)**: Secured a "2 consecutive limit up" with a latest price of 13.89 yuan, up 9.98%. As a leading player in lithium hexafluorophosphate, the company has an annual production capacity of 22,000 tons, benefiting from the growing demand for lithium batteries [2] - **Fengyuan Co. (002805.SZ)**: Recorded its first limit up with a latest price of 14.61 yuan, up 10.02%. The company has a dual-track strategy in lithium battery cathode materials, with a production capacity of 125,000 tons for lithium iron phosphate and 15,000 tons for ternary materials, establishing strong partnerships with major clients [3] - **Jinyinhai Co. (300619.SZ)**: Achieved a 20% limit up with a latest price of 33.16 yuan. The company is a leader in automated mixing equipment for lithium batteries and provides integrated solutions for both lithium-ion and sodium-ion battery production [4] - **Hongxing Development (600367.SS)**: Recorded its first limit up with a latest price of 18.01 yuan, up 10.02%. The company has significant production capacity in manganese-based lithium battery materials, with an annual output of 30,000 tons for both electrolytic manganese dioxide and high-purity manganese sulfate [5] - **Guanghua Technology (002741.SZ)**: Achieved its first limit up with a latest price of 22.35 yuan, up 9.99%. The company has a diverse range of lithium battery materials and is involved in the recycling of retired batteries, creating a closed-loop industry chain from material production to recycling [6]

Group 1 - The solid-state battery sector in the A-share market continues to show strong performance, with several companies experiencing significant stock price increases [1] - Patel's stock surged over 24%, while other companies like Jinyinhe and Huasheng Lithium Battery hit the daily limit of 20% increase [1] - Other notable performers include Lijia Technology with an increase of over 18%, and XianDao Intelligent with a rise of over 17% [1] Group 2 - Patel's total market capitalization is approximately 2.02 billion, with a year-to-date increase of 138.26% [2] - Jinyinhe has a market cap of 5.77 billion, with a year-to-date increase of 79.24% [2] - XianDao Intelligent's market cap stands at 82.5 billion, with a remarkable year-to-date increase of 163.72% [2]

Core Viewpoint - The company emphasizes the critical role of manganese in the development of solid-state batteries and acknowledges market judgments regarding this element [1] Production Capacity - The company has an annual production capacity of 30,000 tons for both electrolytic manganese dioxide and high-purity manganese sulfate [1] - The company possesses production technology for manganese tetroxide, which has completed pilot testing but has not yet produced any products [1]

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Key Points - The company will distribute a cash dividend of 0.03 CNY per share [1][2] - The total cash dividend to be distributed amounts to 10,233,927.06 CNY based on a total share capital of 341,130,902 shares [2] - The record date for shareholders is set for September 10, 2025, with the last trading day and ex-dividend date also on September 11, 2025 [1][2] - The profit distribution plan was approved by the board on August 21, 2025, and is not expected to exceed 30% of the net profit attributable to shareholders for the first half of 2025 [1][2] - The distribution will be managed by China Securities Depository and Clearing Corporation Limited, Shanghai Branch [2][3] - Shareholders who hold shares for more than one year will not be subject to individual income tax on the dividend [3][4] - For shareholders holding shares for one month or less, a 20% tax will be applied to the dividend income [4] - The net dividend after tax for overseas investors will be 0.027 CNY per share, subject to a 10% withholding tax [5][6]

证券日报网讯 9月2日晚间，红星发展发布公告称，2025年半年度利润分配方案为A股每股现金红利0.03 元（含税），股权登记日为2025年9月10日，除权（息）日及现金红利发放日均为2025年9月11日。 （文章来源：证券日报） ...

证券代码：600367 证券简称：红星发展 公告编号：2025-040 贵州红星发展股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.03元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/9/10 | － | 2025/9/11 | 2025/9/11 | 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 贵州红星发展股份有限公司2025 年 5 月 22 日的2024年年度股东会授权董事会 实施公司 2025 年中期利润分配方案，公司 2025 年中期利润分配现金分红金额不 高于 2025 年半年度合并报表归属于上市公司股东的净利润的 30%。本利润分配方 案经公司 2025 年 8 月 21 日召开的第九届董事会第六次会议审议通过。 二、 分配方案 2. 分派对象： 截至股权登记 ...